Kevin Bae

Non-Social in a Socially Networked World

UK mRNA Vaccine Protocols are going to make you sick. Or at least the vaccine will.

Here’s a link to the UK mRNA vaccine protocols. Pay particular attention to section 4.8 because this is coming to an injection site near you.

Mind you this vaccine was tested over 80% on white males so your mileage may vary if you are anything else. 1 in 10 will experience flu like symptoms after the vaccine plus a pain in the injection area.

Remind me again why we need to take a vaccine that will give 10% of the people the same symptoms as the illness itself? Especially when well over 97% of those who get infected with SARS-CoV-2 and come down with COVID-19 will experience the same thing and fully recover? Why take an unproven vaccine for this when nature will most likely take care of it for free?

The most frequent adverse reactions in participants 16 years of age and older were pain at the injection site (> 80%), fatigue (> 60%), headache (> 50%), myalgia (> 30%), chills (> 30%), arthralgia (> 20%) and pyrexia (> 10%) and were usually mild or moderate in intensity and resolved within a few days after vaccination. If required, symptomatic treatment with analgesic and/or anti-pyretic medicinal products (e.g. paracetamol-containing products) may be used.

Adverse reactions from clinical studies
Adverse reactions reported in clinical studies are listed in this section per MedDRA system organ class, in decreasing order of frequency and seriousness. The frequency is defined as follows: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to <1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000), not known (cannot be estimated from available data).

Blood and lymphatic system disorders
Uncommon: Lymphadenopathy
Nervous system disorders
Very common: Headache
Musculoskeletal and connective tissue disorders
Very common: Arthralgia; myalgia
General disorders and administration site conditions
Very common: Injection-site pain; fatigue; chills; pyrexia

gov.uk

Posted

in

by